Cargando…
High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures
BACKGROUND: Antimicrobial peptide expression is associated with disease activity in inflammatory bowel disease (IBD) patients. IBD patients have abnormal expression of elafin, a human elastase-specific protease inhibitor and antimicrobial peptide. We determined elafin expression in blood, intestine,...
Autores principales: | Wang, Jiani, Ortiz, Christina, Fontenot, Lindsey, Xie, Ying, Ho, Wendy, Mattai, S. Anjani, Shih, David Q., Koon, Hon Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156098/ https://www.ncbi.nlm.nih.gov/pubmed/32287314 http://dx.doi.org/10.1371/journal.pone.0231796 |
Ejemplares similares
-
Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male mice
por: Wang, Jiani, et al.
Publicado: (2020) -
Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
por: Xie, Ying, et al.
Publicado: (2022) -
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn’s disease, and clinical prognosis in inflammatory bowel disease
por: Tran, Diana Hoang-Ngoc, et al.
Publicado: (2017) -
Intestinal Stricture in Crohn's Disease
por: Chang, Chen-Wang, et al.
Publicado: (2015) -
Intestinal strictures in Crohn’s disease: a 2021 update
por: Lin, Xiaoxuan, et al.
Publicado: (2022)